Vimarsana
Biggest News Aggregation in the World

Page 16 - Roche Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Diagnostics Today - Breaking & Trending Today

Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial - Vimarsana News

Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial

Objective To evaluate the impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome. Design Secondary observational analysis of a stepped wedge, cluster randomised controlled trial. Setting 10 secondary and tertiary care centres in Scotland, UK. Participants 48 282 consecutive patients with suspected acute coronary syndrome. Myocardial injury was defined as any high sensitivity assay result for cardiac troponin I >99th centile of 16 ng/L in women and 34 ng/L in men. Intervention Hospital sites were rando...

Source: bmj.com
The principle of digital PCR - Vimarsana News

The principle of digital PCR

Discover Digital PCR: An advanced PCR method that splits reactions into microreactions for precise end-point amplification and absolute quantification of targets using Poisson calculations.

Predisposition Biomarkers Market Analysis and Future Prospects for 2030 - Vimarsana News

Predisposition Biomarkers Market Analysis and Future Prospects for 2030

Predisposition Biomarkers Market Analysis and Future Prospects for 2030

Global Hemostasis Testing Systems Market is poised for remarkable growth, expected to reach US$ 3,66 - Vimarsana News

Global Hemostasis Testing Systems Market is poised for remarkable growth, expected to reach US$ 3,66

Hemostasis Testing Systems MarketThe global hemostasis testing systems market value is likely to jump from US$ 2,149.3 million in 2023 to US$ 3,666 million by 2033. This is expected to be driven by a steady CAGR of 5.5% in the hemostasis testing systems market over the next decade.The market is driven by the increas...

Blood Screening Market worth $3.4 billion by 2028 - Ucommune International (NASDAQ:UK) - Vimarsana News

Blood Screening Market worth $3.4 billion by 2028 - Ucommune International (NASDAQ:UK)

"The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Grifols (Spain), Abbott Laboratories, Inc. (US), Bio-Rad Laboratories, Inc. (US), Danaher (Beckman Coulter, Inc.) (US), bioMérieux